Light bulb icon Did you know?

IN NONFEDERAL HOSPITALS

Olanzapine=8most utilized molecules combined

Olanzapine has the same utilization as the next 8 most utilized molecules combined.1†

The second most frequently prescribed atypical antipsychotic after olanzapine accounts for just 13% of nonfederal hospital utilization.1†

Woman in a pink shirt looking up, smiling
Not an actual patient.

Light bulb icon Did you know?

Olanzapine is on the World Health Organization’s List of Essential Medicines.2

World Health Organization Logo

Olanzapine was approved for medical use in the United States in 1996 and was added to the World Health Organization’s List of Essential Medicines in 2023.2,6,7

People shown on this website are not actual patients.

REFERENCES: 1. Data on file. Parsippany, NJ: Teva Pharmaceuticals USA, Inc. 2. Olanzapine orally disintegrating tablets. Prescribing information. Parsippany, NJ: Teva Pharmaceuticals USA, Inc. 3. Komossa K, Rummel-Kluge C, Hunger H, et al. Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2010;(3):CD006654. 4. Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat. 2019;15:2559-2569. 5. Kolli P, Kelley G, Rosales M, Faden J, Serdenes R. Olanzapine pharmacokinetics: a clinical review of current insights and remaining questions. Pharmgenomics Pers Med. 2023;16:1097-1108. 6. World Health Organization. World Health Organization model list of essential medicines - 23rd list, 2023. Accessed December 2, 2024. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02 7. World Health Organization. World Health Organization model list of essential medicines – 22nd List, 2021. Accessed December 10, 2024. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02

Allyable tool icon